82 FR 14806 - Genomic Medicine Program Advisory Committee; Notice of Meeting

DEPARTMENT OF VETERANS AFFAIRS

Federal Register Volume 82, Issue 54 (March 22, 2017)

[Federal Register Volume 82, Number 54 (Wednesday, March 22, 2017)]
[Notices]
[Page 14806]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-05664]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Genomic Medicine Program Advisory Committee; Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under the 
Federal Advisory Committee Act, 5 U.S.C. App. 2, that the Genomic 
Medicine Program Advisory Committee will meet on May 22, 2017, at the 
Hilton Garden Inn, Washington, DC, U.S. Capitol, 1225 1st Street NE., 
Washington, DC 20002. The meeting will convene at 9:00 a.m. and adjourn 
at 4:30 p.m. The meeting is open to the public.
    The purpose of the Committee is to provide advice and make 
recommendations to the Secretary of VA on using genetic information to 
optimize medical care for Veterans and to enhance development of tests 
and treatments for diseases particularly relevant to Veterans.
    The Committee will receive program updates and continue to provide 
insight into optimal ways for VA to incorporate genomic information 
into its health care program while applying appropriate ethical 
oversight and protecting the privacy of Veterans. The meeting focus 
will be on updates on the progress and planned characterization of the 
Million Veteran Program (MVP) samples and data access for the MVP, as 
well as updates from other national research programs such as the 
Kaiser Permanante. The Committee will also receive an update from the 
VA Clinical Genomics Service. Public comments will be received at 3:30 
p.m. and are limited to 5 minutes each. Individuals who speak are 
invited to submit a 1-2 page summary of their comments for inclusion in 
the official meeting record to Dr. Sumitra Muralidhar, Designated 
Federal Officer, 810 Vermont Avenue NW., Washington, DC, 20420, or by 
email at [email protected]. Any member of the public seeking 
additional information should contact Dr. Muralidhar at (202) 443-5679.

    Dated: March 17, 2017.
LaTonya L. Small,
Advisory Committee Management Officer.
[FR Doc. 2017-05664 Filed 3-21-17; 8:45 am]
 BILLING CODE P